These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6318857)

  • 21. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Factors and mechanisms affecting the rheological properties of the blood in ischemic heart disease].
    Furkalo NK; Ivashchenko TI; Bol'shakova RM; Progonnaia VV; Romanenko AI
    Ter Arkh; 1982; 54(11):119-23. PubMed ID: 7157161
    [No Abstract]   [Full Text] [Related]  

  • 23. [Types of hyperlipoproteinemia and thrombocyte survival in ischemic heart disease].
    Belousov IuB; Dudaev VA; Shmushkovich BI; Botasheva MM
    Kardiologiia; 1977 May; 17(5):24-31. PubMed ID: 886745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD).
    Meade TW; Cooper JA; Miller GJ
    Thromb Haemost; 1997 Aug; 78(2):926-9. PubMed ID: 9268196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The electrophoretic mobility of red cells and platelets and the plasma viscosity in coronary heart disease.
    Karppinen K
    Acta Med Scand Suppl; 1970; 506():1-42. PubMed ID: 5268180
    [No Abstract]   [Full Text] [Related]  

  • 26. Endothelium dysfunction in the coronary circulation.
    Lüscher TF; Noll G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
    Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L
    Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
    Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thromboxane biosynthesis in platelets of diabetic and coronary artery diseased patients.
    Butkus A; Shirey EK; Schumacher OP
    Artery; 1982; 11(3):238-51. PubMed ID: 7184495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thermo-induced structural reorganizations of platelet membranes as affected by aggregation inducers and inhibitors].
    Kubatiev AA; Rudenko TS; Chernikhovskaia TI; Sushkevich GN; Zhdanov RI
    Biull Eksp Biol Med; 1993 Jan; 115(1):15-7. PubMed ID: 8054562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of verapamil on the functional status of thrombocytes in patients with ischemic heart disease].
    Belousov IuB; Azizova OA; Razumov VB; Gutkin AB; Borin ML
    Kardiologiia; 1989 Feb; 29(2):42-5. PubMed ID: 2724766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of platelet membrane structure in patients with chronic glomerulonephritis (CGN)].
    Zdrojewski Z; Nowak J; Raszeja-Specht A; Skibowska A; Kustosz J; Rutkowski B
    Przegl Lek; 1996; 53(5):431-3. PubMed ID: 8754408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of erythrocyte membrane cholesterol in disorders of their structuro-functional status in patients with ischemic heart disease].
    Liusov VA; Razumov VB; Redchits EG; Nemirovskiĭ LE; Savenkov MP
    Kardiologiia; 1987 Jan; 27(1):86-8. PubMed ID: 3031356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of platelet aggregation by immune complexes. I. Clinical studies].
    Shkhvatsabaia IK; Osipov SG; Turlubekov KK; Titov VN; Kasatkina LV
    Biull Eksp Biol Med; 1982 Nov; 94(11):27-9. PubMed ID: 7150731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes.
    Marton Z; Horvath B; Alexy T; Kesmarky G; Gyevnar Z; Czopf L; Habon T; Kovacs L; Papp E; Mezey B; Roth E; Juricskay I; Toth K
    Clin Hemorheol Microcirc; 2003; 29(2):81-94. PubMed ID: 14610303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyperbaric oxygenation and antiaggregants: effects on platelet function in patients with ischemic heart disease].
    Seriakov VV; Feofanova ID
    Anesteziol Reanimatol; 1997; (2):31-3. PubMed ID: 9221683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease].
    Jost S; Lichtlen PR
    Z Kardiol; 1995 Aug; 84(8):577-95. PubMed ID: 7571764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Paramagnetic probe study of photoinduced rearrangements in photoreceptor membranes].
    Vlasova SA; Krugliakova KE; Ostrovskiĭ MA
    Dokl Akad Nauk SSSR; 1975 Aug; 223(4):1001-4. PubMed ID: 173502
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effects of mexicor on thrombocyte aggregation, blood viscosity, hemodynamics, and the clinical course of coronary artery disease].
    Kazantsev DN; Prolubshchikov VA; Sokolianskiĭ NV; Chernov SA
    Klin Med (Mosk); 2006; 84(10):59-62. PubMed ID: 17201277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.